Skip to content
★ Sign in to follow
AB

Astrid Borkowski

HilleVax, Inc.
Total declarations
9
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (6 ops.)
€649k

Latest filing published 12 Feb 2024 for HilleVax, Inc., €54k.

Filing timeline

BuySale
Astrid Borkowski

Insider track record

Disclosed buys
0
Disclosed sells
6
Signal history

Astrid Borkowski: trading record in brief

Astrid Borkowski appears in our data through filings on HilleVax, Inc. shares, published by SEC (Form 4). The record holds 9 filings, for trades running from 1 February 2023 to 8 February 2024.

No open-market purchase appears, only 6 sales worth €649k. Besides market trades, the filings include 2 share grants. Since January 2024: no purchases and 1 sale on the market.

On 12 February 2024 came the latest disclosure, a share grant in HilleVax, Inc. Typically, a trade is published a median of 3 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Astrid Borkowski

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations7 total
  • ▼
    Chief Medical OfficerExecutivesHilleVax, Inc.
    58,726 USD30SEC
    3,933 shares@ US$14.93158.2% of flowCommon StockSEC:0000950170-24-014059:0
  • ▼
    Chief Medical OfficerExecutivesHilleVax, Inc.
    155,000 USD13SEC
    10,000 shares@ US$15.5021.3% of flowCommon StockSEC:0000950170-23-071185:0
  • ▼
    Chief Medical OfficerExecutivesHilleVax, Inc.
    142,000 USD13SEC
    10,000 shares@ US$14.2019.7% of flowCommon StockSEC:0000950170-23-068230:0
  • ▼
    Chief Medical OfficerExecutivesHilleVax, Inc.
    140,000 USD13SEC
    10,000 shares@ US$14.0019.5% of flowCommon StockSEC:0000950170-23-065166:0
  • ▼
    Chief Medical OfficerExecutivesHilleVax, Inc.
    65,000 USD12SEC
    5,000 shares@ US$13.009.2% of flowCommon StockSEC:0000950170-23-063132:0
  • ●
    Chief Medical OfficerExecutivesHilleVax, Inc.
    161,100 USD13SEC
    10,000 shares@ US$16.1122.1% of flowCommon StockSEC:0000899243-23-016313:0
  • ◆
    Chief Medical OfficerExecutivesHilleVax, Inc.
    0SEC
    51,333 shares0Common StockSEC:0000899243-23-003859:0

7 of 7 declarations